Results 191 to 200 of about 218,877 (245)

Correction: Case Report: Fecal microbiota transplantation via capsules ameliorated clinical outcomes in a patient with multiple sclerosis. [PDF]

open access: yesFront Immunol
Bibbò S   +11 more
europepmc   +1 more source

No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12. [PDF]

open access: yesBlood Adv
Laurenti L   +31 more
europepmc   +1 more source

Correction: An evolutionarily conserved role for separase in the regulation of nuclear lamins. [PDF]

open access: yesCell Death Discov
Cipressa F   +12 more
europepmc   +1 more source

Access to emerging health technologies in aging: from innovation to inclusion. [PDF]

open access: yesJ Frailty Aging
Marzetti E   +3 more
europepmc   +1 more source

Structure-Guided Prioritization and Synthesis of New Ligands for GPR17 Receptor. [PDF]

open access: yesACS Omega
Rabuffetti M   +10 more
europepmc   +1 more source

Effects of antenatal education on maternal anxiety and depression in pregnancy and postpartum period in Italy: modest and transient symptom reductions. [PDF]

open access: yesFront Psychol
Camoni L   +5 more
europepmc   +1 more source

Porous Poly(ε‐Caprolactone)/Keratin Composite Scaffolds: Structural Features, Degradation Behavior and Cell‐Material Interactions

open access: yesJournal of Applied Polymer Science, EarlyView.
ABSTRACT Porous scaffolds based on pure poly(ε‐caprolactone) (PCL) and on biocomposite made of PCL and feather‐extracted β‐keratin (FK) were fabricated by salt‐leaching method. FK was incorporated into PCL to address the limited bioactivity and hydrophobic nature of PCL, with the aim of improving cell–material interactions for bone tissue engineering ...
Gianluca Rinaldi   +6 more
wiley   +1 more source

Robotic cholecystectomy during surgical training: learning curve and perioperative outcomes of 441 consecutive cases in a high-volume teaching center. [PDF]

open access: yesJ Robot Surg
Gravante G   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy